News about Drug Discovery & Development

PillSafe Launches 'Smart' Pill Bottle for Prescription Drugs

PillSafe® uses new disruptive technology, a groundbreaking economical “smart” pill bottle for prescription drugs, designed by doctors to ensure safety and compliance with medication in the fight against addictive drugs.

Drug Discovery & Development | 04/01/2024 | By Manvi |  541

Venus Remedies Secures Marketing Approval from Israel, Colombia for Two Oncology Drugs

Building on its international presence in the oncology space, Venus Remedies has secured marketing authorisation for docetaxel from Israel and cytarabine from Colombia.

Drug Discovery & Development | 29/12/2023 | By Manvi |  664

SEQSTER Launches CoRD Accelerating Drug Discovery and Deep Insights for Pharma

This innovative tool parses, standardizes, and transforms data into a clean, common form, eliminating barriers to comprehensive healthcare insights.

Drug Discovery & Development | 12/12/2023 | By Manvi |  263

Lupin Launches World's First Fixed-dose Triple Combination Drug

Lupin Vilfuro-G® is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide, for the long-term management and treatment of moderate to severe COPD.

Drug Discovery & Development | 27/11/2023 | By Manvi |  710

Lupin Gets Approval from US FDA for Pitavastatin Tablets

Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in Adults with primary hyperlipidemia, Adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH).

Drug Discovery & Development | 22/11/2023 | By Manvi |  412

Qubit Pharmaceuticals Announces Euro 4.5 Mn Investment in New Drug Discovery Platform

The initiative is supported by Bpifrance with a total investment of €2 million via the Investissements d'Avenir and France 2030 programs.

Drug Discovery & Development | 20/11/2023 | By Manvi |  646

Venus Remedies Granted Market Authorization for Bleomycin 15,000 IU in UK

This remarkable milestone not only expands the pharma giant's global presence but also underscores its commitment to advancing cancer care with innovative solutions.

Drug Discovery & Development | 30/10/2023 | By Manvi |  698

Sun Pharma Recalls 144 Bottles of Anti-Depression Drug from US Market

Sun Pharmaceutical Industries Inc has recalled 144 bottles of a generic anti-depression medicine from the US market due to a manufacturing issue, according to the U.S. Food and Drug Administration (FDA).

Drug Discovery & Development | 23/10/2023 | By Manvi |  421

Glenmark Pharmaceuticals Gets ANDA Approval for Apremilast Tablets, 10 mg, 20 mg and 30 mg

According to IQVIATM sales data for the 12-month period ending August 2023, the Otezla® Tablets, 10 mg, 20 mg, and 30 mg market2 achieved annual sales of approximately USD 3.7 billion.

Drug Discovery & Development | 18/10/2023 | By Manvi |  791

Venus Remedies Gets Marketing Approval for Six Chemotherapy Drugs from Philippines

Venus Remedies has secured marketing authorisation for bortezomib, cisplatin, doxorubicin, docetaxel, flurouracil and paclitaxel from the Philippines, thus making it a significant market for the company from the ASEAN region.

Drug Discovery & Development | 18/10/2023 | By Manvi |  630